Back
ESC Premium Access

Introduction - Safety first: avoiding adverse events with new cardiovascular drugs

Session: Meet the Experts - Safety first: avoiding adverse events with new cardiovascular drugs
Topic: Cardiovascular Pharmacotherapy
Speaker: Doctor M. Alonso Garcia (London, GB)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Maria Angeles Alonso Garcia

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
4 presentations
0 follower

5 more presentations in this session

Safety first: avoiding adverse events with new cardiovascular drugs - Panel

Access
Thumbnail

Scenario 1 - Adverse events of new lipid lowering drugs.

Speaker: Doctor T. Hall (Oslo, NO)

Access
Slides
Video
Thumbnail

Scenario 2 - Neprilysin inhibitors in heart failure: safety and adverse events

Speaker: Assistant Professor M. Kaluzna-Oleksy (Poznan, PL)

Access
Slides
Thumbnail

Scenario 3 - Long-term safety of new anti-diabetic drugs.

Speaker: Associate Professor A. Niessner (Vienna, AT)

Access
Slides
Video
Thumbnail

Safety first: avoiding adverse events with new cardiovascular drugs - Take Home Message.

Speaker: Professor J. Tamargo (Madrid, ES)

Access
Slides
Video
Thumbnail

Access the full session

Meet the Experts - Safety first: avoiding adverse events with new cardiovascular drugs

Speakers: Doctor M. Alonso Garcia, Doctor T. Hall, Assistant Professor M. Kaluzna-Oleksy, Associate Professor A. Niessner, Professor J. Tamargo
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb